In patients, heavy infiltration of primary breast tumor with CD207+Langerin+ immature DCs are a common pathological feature and, while their presence does not directly affect prognosis in themselves, it is likely they are blunting the immune response to immunotherapies [70,71]. The gene discussed is CD207; the disease is breast neoplasm.